Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patterns of Genetic Expression Associated to Sensibility to Doxorubicin Versus Docetaxel as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

NCT00123929 is registered in ClinicalTrials.gov with Hospital San Carlos, Madrid as lead sponsor.

NCT NCT00123929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patterns of Genetic Expression Associated to Sensibility to Doxorubicin Versus Docetaxel as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Lead sponsor
Hospital San Carlos, Madrid
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2009
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer